The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer.
Zhang Y, Chen G, Chen X, Fang W, Gao F, Yang Y, Zhao Y, Ma Y, Hong S, Zhang Z, Miao S, Wu M, Huang X, Luo Y, Zhou C, Gong R, Huang Y, Chen L, Zhou N, Zhao H, Zhang L.
Zhang Y, et al. Among authors: chen l, chen g, chen x.
J Cancer. 2017 Jul 2;8(10):1865-1871. doi: 10.7150/jca.19867. eCollection 2017.
J Cancer. 2017.
PMID: 28819384
Free PMC article.